Cargando…

Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program

Background. This work examines the occurrence of interval colorectal cancers (CRCs) in the Ontario ColonCancerCheck (CCC) program. We define interval CRC as CRC diagnosed within 2 years following normal guaiac fecal occult blood testing (gFOBT). Methods. Persons aged 50–74 who completed a baseline C...

Descripción completa

Detalles Bibliográficos
Autores principales: Paszat, Lawrence, Sutradhar, Rinku, Tinmouth, Jill, Baxter, Nancy, Rabeneck, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904697/
https://www.ncbi.nlm.nih.gov/pubmed/27446842
http://dx.doi.org/10.1155/2016/4768728
_version_ 1782437189807767552
author Paszat, Lawrence
Sutradhar, Rinku
Tinmouth, Jill
Baxter, Nancy
Rabeneck, Linda
author_facet Paszat, Lawrence
Sutradhar, Rinku
Tinmouth, Jill
Baxter, Nancy
Rabeneck, Linda
author_sort Paszat, Lawrence
collection PubMed
description Background. This work examines the occurrence of interval colorectal cancers (CRCs) in the Ontario ColonCancerCheck (CCC) program. We define interval CRC as CRC diagnosed within 2 years following normal guaiac fecal occult blood testing (gFOBT). Methods. Persons aged 50–74 who completed a baseline CCC gFOBT kit in 2008 and 2009, without a prior history of CRC, or recent colonoscopy, flexible sigmoidoscopy, or gFOBT, were identified. Rates of CRC following positive and normal results at baseline and subsequent gFOBT screens were computed and overall survival was compared between those following positive and normal results. Results. Interval CRC was diagnosed within 24 months following the baseline screen among 0.16% of normals and following the subsequent screen among 0.18% of normals. Interval cancers comprised 38.70% of CRC following the baseline screen and 50.86% following the subsequent screen. Adjusting for age and sex, the hazard ratio (HR) for death following interval cancer compared to CRC following positive result was 1.65 (1.32, 2.05) following the first screen and 1.71 (1.00, 2.91) following the second screen. Conclusion. Interval CRCs following gFOBT screening comprise a significant proportion of CRC diagnosed within 2 years after gFOBT testing and are associated with a higher risk of death.
format Online
Article
Text
id pubmed-4904697
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49046972016-06-30 Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program Paszat, Lawrence Sutradhar, Rinku Tinmouth, Jill Baxter, Nancy Rabeneck, Linda Can J Gastroenterol Hepatol Research Article Background. This work examines the occurrence of interval colorectal cancers (CRCs) in the Ontario ColonCancerCheck (CCC) program. We define interval CRC as CRC diagnosed within 2 years following normal guaiac fecal occult blood testing (gFOBT). Methods. Persons aged 50–74 who completed a baseline CCC gFOBT kit in 2008 and 2009, without a prior history of CRC, or recent colonoscopy, flexible sigmoidoscopy, or gFOBT, were identified. Rates of CRC following positive and normal results at baseline and subsequent gFOBT screens were computed and overall survival was compared between those following positive and normal results. Results. Interval CRC was diagnosed within 24 months following the baseline screen among 0.16% of normals and following the subsequent screen among 0.18% of normals. Interval cancers comprised 38.70% of CRC following the baseline screen and 50.86% following the subsequent screen. Adjusting for age and sex, the hazard ratio (HR) for death following interval cancer compared to CRC following positive result was 1.65 (1.32, 2.05) following the first screen and 1.71 (1.00, 2.91) following the second screen. Conclusion. Interval CRCs following gFOBT screening comprise a significant proportion of CRC diagnosed within 2 years after gFOBT testing and are associated with a higher risk of death. Hindawi Publishing Corporation 2016 2016-05-08 /pmc/articles/PMC4904697/ /pubmed/27446842 http://dx.doi.org/10.1155/2016/4768728 Text en Copyright © 2016 Lawrence Paszat et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Paszat, Lawrence
Sutradhar, Rinku
Tinmouth, Jill
Baxter, Nancy
Rabeneck, Linda
Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
title Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
title_full Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
title_fullStr Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
title_full_unstemmed Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
title_short Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program
title_sort interval colorectal cancers following guaiac fecal occult blood testing in the ontario coloncancercheck program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904697/
https://www.ncbi.nlm.nih.gov/pubmed/27446842
http://dx.doi.org/10.1155/2016/4768728
work_keys_str_mv AT paszatlawrence intervalcolorectalcancersfollowingguaiacfecaloccultbloodtestingintheontariocoloncancercheckprogram
AT sutradharrinku intervalcolorectalcancersfollowingguaiacfecaloccultbloodtestingintheontariocoloncancercheckprogram
AT tinmouthjill intervalcolorectalcancersfollowingguaiacfecaloccultbloodtestingintheontariocoloncancercheckprogram
AT baxternancy intervalcolorectalcancersfollowingguaiacfecaloccultbloodtestingintheontariocoloncancercheckprogram
AT rabenecklinda intervalcolorectalcancersfollowingguaiacfecaloccultbloodtestingintheontariocoloncancercheckprogram